Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced financial results for the second quarter of 2025 and provided general business updates.

Recent clinical trials like ADRIATIC and IMforte are shaping the future of small cell lung cancer (SCLC) treatment, explained Angel Qin, MD. She also emphasized the growing role of immunotherapy in ...

Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a Phase I study titled ‘A Phase I Dose ...

By Kathy Gaillard Pastor Richard D. Shaw grew up in Marion, AL, in the same birthplace of civil rights icons Coretta Scott King and Andrew Young’s wife (Jean Childs Young). […] ...

Reports Q2 revenue $110.0M, consensus $125.02M. “Zai Lab (ZLAB) is entering a pivotal period – defined by innovation, scale and strong execution,” ...

Understanding the type and stage of cancer is crucial for developing effective treatment plan. Here's what a surgical oncologist wants you to know.

Minghui Pharmaceutical ("Minghui"), a late-stage clinical biopharmaceutical company, today announced the closing of a USD 131 ...

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced financial results for the second quarter of 2025, along with ...